White Noise and In-vitro Fertilizasyon
Launched by YASEMIN SÖKMEN · May 29, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of white noise during in vitro fertilization (IVF) to see if it can help reduce pain, anxiety, and improve comfort for women undergoing the procedure. In vitro fertilization is a process where eggs and sperm are combined in a lab, and then embryos are placed into the uterus with a thin tube called a catheter. While there are many ways to manage stress during IVF, like meditation and acupuncture, researchers want to explore how white noise might help as well.
To participate in this study, women must be between the ages of 18 and 35, diagnosed with primary infertility, and able to understand and speak Turkish. They should not have any psychiatric conditions or have undergone certain fertility treatments in the last month. Participants will be divided into two groups: one that will hear white noise and another that will not. Throughout the study, data will be collected to measure their levels of pain, anxiety, and comfort. This research is important because it may provide new ways to support women during IVF, making the experience less stressful and more comfortable.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women between the ages of 18-35,
- • Diagnosed with primary infertility,
- • Not diagnosed with a psychiatric disease,
- • Who can speak and understand Turkish,
- • Who are at least primary school graduates will be included in the study
- Exclusion Criteria:
- • Women who have undergone oocyte pick-up within the last month,
- • Who have undergone intrauterine insemination within the last month,
- • Who have undergone embryo transfer within the last month,
- • Who have undergone any other pharmacological or non-pharmacological application that may reduce stress will be excluded.
About Yasemin Sökmen
Yasemin Sökmen is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative trial designs and robust methodologies. With a focus on fostering collaborative partnerships within the healthcare community, Ms. Sökmen leverages her extensive expertise in clinical operations, regulatory compliance, and data management to ensure the successful execution of trials across various therapeutic areas. Her leadership emphasizes ethical standards, patient safety, and the integration of cutting-edge technology to streamline processes and enhance data integrity, ultimately contributing to the development of effective therapeutic solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Samsun, Atakum, Turkey
Patients applied
Trial Officials
Yasemin Sökmen, Asistant professor
Principal Investigator
Ondokuz Mayıs University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported